PennyMac Mortgage Investment Trust (PMT) Earnings Call Transcript & Summary

January 29, 2026

New York Stock Exchange US Real Estate Mortgage Real Estate Investment Trusts (REITs) earnings 29 min

Earnings Call Speaker Segments

David Spector

executive
#1

Thanks, operator. Good afternoon, everyone, and I'm glad you could all be with us today for the call covering our fourth quarter and full year 2025 results. If you'll turn to slide 3, you'll see that PMT posted solid financial performance in Q4, generating $42 million of net income attributable to common shareholders, which works out to a 13% annualized return on common equity. On a diluted basis, earnings per share reached $0.48, topping the $0.40 per share quarterly dividend PMT pays, while book value per share ended the year at $15.25, an increase from $15.16 as of September 30. Dan is going to walk through PMT's Q4 financials in more depth a bit later on. Turning to slide 4, I'd like to highlight how much progress we made in 2025, when we ramped up our efforts to create organic investments through private label securitizations. Throughout that year, as the slide shows, we finished 19 securitizations altogether, representing $6.7 billion in UPB — a big jump compared with only 2 securitizations in 2024. The retained investments coming out of those securitizations climbed to $528 million, roughly a tenfold rise from the $54 million recorded in 2024. Thanks to this steady rhythm of securitization work, PMT firmly secured its place as one of the top three issuers of prime non-Agency MBS in 2025. Meanwhile, we shifted capital around to get a better return profile out of PMT. That meant buying $876 million in Agency floating rate MBS and selling $195 million in opportunistic GSE-issued CRT investments, which had generated sizable gains for us. The reason we exited those GSE-issued CRT investments is that their expected returns going forward had dropped under the return thresholds we target, and selling them released capital that PMT could put into newly created assets offering better expected returns through the private label securitization activity we keep running. Now on slide six, the synergistic relationship we have with PFSI is still a competitive advantage that is both unique and proven. To start, PMT benefits from PFSI's top-tier operating infrastructure, which encompasses an experienced and deep management group, servicing operations at scale, and a sizable, nimble origination business spanning multiple channels — this gives PMT a steady, high-quality supply of loans to invest in. Next, PMT can put capital to work in long-term mortgage assets efficiently, avoiding the operational strain that comes with originating and servicing loans. Finally, because PFSI has extensive reach into the origination market and PMT can carry out private label securitizations, PMT gains a distinctive chance to invest in organically generated investments offering appealing risk-adjusted returns; moreover, as PFSI keeps expanding its overall portion of loan production, PMT should see still more chances to grow its portfolio organically. Moving on to slide 7. Roughly 60% of PMT's shareholder equity sits in seasoned MSR and GSE credit risk transfer investments, which are unique to us. Within that, mortgage servicing rights make up 46% of shareholder equity and deliver steady cash flow, since the loans behind them carry a weighted average coupon of 3.9%, putting them well out of the money. Our GSE credit risk transfer investments account for 13% of shareholder equity and are made up of seasoned loans written between 2015 and 2020. With a weighted average current LTV of 46%, we continue to expect that lifetime losses actually realized on this portfolio will remain contained. Slide 8 highlights just how robust our securitization activity was in Q4, and how rapidly we can expand that business. Eight securitizations were finished, amounting to $2.8 billion in UPB, and we kept $184 million in new investments. Q4 activity featured three non-owner-occupied deals, three jumbo deals, and two Agency-eligible owner-occupied deals. Following the quarter's close, momentum has carried on, with three more securitizations wrapped up, adding up to $1.1 billion in UPB. Going forward, assuming this pace holds, we presently anticipate finishing roughly 30 securitizations during 2026, with targeted returns on equity for these retained investments sitting in the low to mid-teens. The pie charts on Slide 9 show how actively we manage the portfolio to maximize risk-adjusted returns. As diligent stewards of capital, we aim to optimize returns by putting capital back to work in assets that maximize risk-adjusted returns, shifting out of lower-yielding assets and into high-quality investments offering superior return profiles. Our focus stays on refining our allocation toward investments with targeted ROEs of 13%-15%, and by strategically redeploying capital into these higher-returning assets, we are effectively lifting the long-term return potential of our entire portfolio. Moving to slide 10, you can observe the average quarterly run rate return potential anticipated from PMT's investment strategies across the coming four quarters. PMT's present run rate shows a quarterly average of $0.40 per share, a modest decline from $0.42 per share the quarter before. Like we said before, we're planning to put more money into senior and subordinate non-Agency bonds that add value, mostly by creating our own securitizations. When it comes to strategies that react to interest rates, the returns we're expecting haven't moved from last quarter, because the drop in potential returns from MSRs due to higher prepayment assumptions was offset by projected hedging costs coming down. In correspondent production, margins have gotten tighter, so our return outlook for that strategy is worse than it was a quarter ago. Our legacy investments provide a reliable foundation for continued strong results, and we've successfully repositioned PMT as a top player in the private label securitization space, where we originate new investments ourselves and lift our overall returns. As we look ahead, I'm confident this broad, diversified investment platform will support our ability to continue generating earnings that comfortably exceed what we pay out in dividends, while also building long-term value for shareholders. With that, I'll turn it over to Dan, who will walk through the fourth quarter's financial results.

Daniel Perotti

executive
#2

Appreciate that, David. For Q4, income attributable to common stockholders was $42 million — that's $0.48 on a diluted per-share basis — translating into a 13% annualized return on equity for common shareholders. Our strategies exposed to credit risk contributed $24 million in pre-tax income, which equates to a 27% annualized ROE. CRT investments we originated ourselves generated $12 million in gains: $8 million in realized carry gains, plus $4 million in mark-to-market value gains driven by tightening credit spreads. Holdings of subordinate MBS tied to our private label securitizations yielded $11 million in gains, $9 million of which came from market-driven value increases. On the interest rate-sensitive side, pre-tax income was $28 million, an annualized ROE of 10%. Faster prepayment speeds this quarter weighed on this segment's results, causing our MSR asset to run off more quickly. For this segment, income excluding market-driven value changes totaled $21 million, down from $36 million the previous quarter. Even so, net favorable results came from our hedging activities during the quarter, as the $26 million rise in MSR fair value was partially offset by $7 million of net decreases in the fair value of MBS and interest rate hedges, including the related tax benefit. Closing out the year, the value of our MSR asset came in at $3.6 billion. That's down a bit versus the quarter before. What happened is that we saw gains tied to fair value input changes, plus new MSRs coming from production, but those were canceled out by heavier runoff. Looking at delinquency across PMT's MSR portfolio, which is mostly conventional, things stayed flat overall. On the servicing advance side, the figure climbed to $97 million, up from $63 million the quarter prior, driven by property tax payments that come with the season. We have nothing outstanding when it comes to principal and interest advances. Over in correspondent production, the segment recorded a pre-tax loss of $1 million. The main drivers of that negative outcome were wider spreads on jumbo loans while they were being aggregated, plus thinner margins across the channel as competition picked up over the quarter. Under our fulfillment agreement with PFSI, the unpaid principal balance of correspondent production loans we acquired totaled $3.7 billion. That figure breaks down into $2.9 billion in UPB of conventional conforming correspondent volume and $800 million in UPB of correspondent volume that was non-Agency-eligible. During the fourth quarter, PMT bought 17% of PFSI's total conventional conforming correspondent production, along with 100% of its non-Agency-eligible correspondent production. Looking ahead to the first quarter of 2026, PMT anticipates purchasing between 15% and 25% of conventional conforming correspondent production, plus 100% of correspondent non-Agency-eligible loan volume, which matches the levels seen in recent periods. Separately, PMT picked up $1.8 billion in UPB of loans from PFSI's production that fell outside the fulfillment agreement, intending to include them in private label securitizations. On the fulfillment side, our weighted average fee rate came in at 18 basis points, matching what we saw the quarter before. Taking everything together, PMT generated $21 million in net income across its strategies when you set aside market-driven value changes — a decline versus the previous quarter, driven mostly by a smaller contribution from the correspondent segment along with higher MSR runoff, which we touched on earlier. If you turn to Slide 15, we'd like to highlight the flexible, sophisticated financing structures PMT has put in place to support its diverse investment portfolio. During the quarter, we took advantage of opportunistic reopenings of our Exchangeable Senior Notes maturing in 2029, raising $150 million in new unsecured financing. Right now, we're planning to retire the $345 million of Exchangeable Senior Notes maturing in 2026 by tapping capacity on financing lines we already have in place. Moving to Slide 16, PMT's overall debt-to-equity ratio climbed to about 10-to-1 from 9-to-1 as of September 30, reflecting our ongoing practice of keeping investments from securitizations. That increase in total debt-to-equity tracks growth in non-recourse debt associated with those transactions, where accounting rules require every securitized loan to be consolidated onto our balance sheet. As a reminder, this debt gets repaid only out of cash flows from the underlying loans inside each private label securitization, which caps any additional exposure for PMT. Our view remains that debt-to-equity, once non-recourse debt is excluded, is the finest metric for gauging our core leverage, and that ratio stayed inside our expected range at 6-to-1. We anticipate the gap between these two metrics will keep widening as our securitization program expands. At this point we'll take questions. Operator?

Doug Harter

analyst
#3

Great, thanks. I was just hoping you could discuss what return expectations look like for the interest rate strategy. My assumption is that prepayments likely remain elevated. How do you counteract that drop in profitability to return to the target range?

Daniel Perotti

executive
#4

Overall, when it comes to the MSRs, only a limited share of them actually respond to higher-level interest rates moving up. So it really takes a mix of extra recapture, which we anticipate will increase on those loans throughout the year via PMT's recapture provider, PFSI. Plus, we expect the effect of those prepayments to become somewhat less concentrated as the year goes on, simply because of what portion of the portfolio they make up and the fact that we're adding more slowly while that overall slice of the portfolio generally isn't growing quickly. That said, I'd point out that on the whole, regarding the... In a way, those MSRs should be considered within the broader interest rate sensitive strategy, which, if you check our run rate on page 10 of the earnings presentation, stayed at that 12.5% annualized ROE overall. Therefore, there's some complementarity between those MSRs and the offsetting interest rate exposure they carry relative to Agency MBS, which, broadly speaking, over the last few quarters, have been boosting returns on equity.

Doug Harter

analyst
#5

Great, thanks, I appreciate it.

Bose George

analyst
#6

Hey, everyone. Good afternoon. Could you discuss what competition looks like on the production side in the non-Agency space?

David Spector

executive
#7

Right, so I'd say it's pretty much in line with what you'd anticipate. On the jumbo front, we're observing quite robust activity from names like Rocket Mortgage over on the retail side, plus UWM on the broker side. I believe we've been beating both of them when you look at the share of what we originate, and that really reflects how dynamically we handle our secondary marketing work. Still, as things stand right now, bank competition isn't something we're running into much. The third name worth bringing up is Redwood Trust — they do pop into the jumbo space every so often. For the most part, though, those are the players we're up against.

Bose George

analyst
#8

Alright, that's actually really useful, thank you. Now, when it comes to how much equity gets allocated toward the non-Agency securitization, how do you expect that to move — say, by the time we reach year-end?

Daniel Perotti

executive
#9

On the whole, I mean, on the whole, if you look once more at the run rate, what our weighted average allocation captures is, essentially, the mean across the coming 12 months. So we've got it sitting at 9%, you know, as an average during those next few months. By the time we reach the end of the year, it runs a few percentage points above that. So, you know, climbing upward, you know, to probably 11 or 12% once the year wraps up.

Bose George

analyst
#10

Alright, that sounds good. Appreciate it.

David Spector

executive
#11

Bose, here's my perspective — when we pursue non-Agency securitization, there's a trade-off we have to weigh. Naturally, we're attracted to the investment returns, but holding onto loans prior to securitizing them carries aggregation risk. So we're working to keep that exposure in check, and bearing in mind — particularly with jumbo securitizations — we're essentially attempting to size and track what that exposure amounts to. That explains why our production in securitizations has expanded considerably. Still, I genuinely believe this is an area where we'll be searching for promising and different approaches to accomplish more, without absorbing the added risk that comes with expanding an aggregation pipeline up to $2 billion-$3 billion.

Jason Weaver

analyst
#12

Hi there, good evening everyone. I appreciate you taking my question. Regarding the chance to securitize, could you share your thoughts on the borrowing expenses observed recently for investor jumbo as well as Agency-eligible transactions? And additionally, are there any older deals you may consider calling and securitizing again in the near future?

David Spector

executive
#13

I'd say that, when it comes to the funding aspect, the market for financing is strong and highly competitive. Consequently, one benefit we've enjoyed is capitalizing on that environment. That said, during Q4, we put in place a facility lacking a mark-to-market component, which matters greatly for managing risk. As you may remember, back during COVID, we had a comparable structure set up, yet it didn't include mark-to-market, meaning we avoided that mark-to-market exposure. So although this doesn't eliminate every bit of mark-to-market risk, it would require an extremely severe occurrence, and the capacity to navigate through such a significant event is something that's been considered. Therefore, there's somewhat of a compromise regarding the expense relative to the dangers. Still, to put it simply, the IR team can follow up with you about the specific figures, but the marketplace is quite competitive right now. A great deal of money is moving in to fund these kinds of assets.

Jason Weaver

analyst
#14

Okay. Thanks. So with a few of those affordability-focused programs the administration is considering, could you discuss how much origination capacity the correspondent channel has — PFSI included — and how far it could scale if demand turns out to be stronger down the road?

David Spector

executive
#15

Sure, look, I'd say the system holds a decent level of capacity for whatever program the GSEs roll out. Clearly, if what gets rolled out resembles a streamlined refi offering in the conventional space, that will bring a degree of refinance demand that exceeds the available capacity. Still, in the end, that resolves on its own. And like I said on the PFSI call, one thing we're seeing out in the market is that there's actually more excess capacity across the sector than I had anticipated. My sense is that's largely because rates coming down has been discussed for as long as the past 12 months, which handed people a chance to build up their capacity. Now, like I said, if something significant gets rolled out and suddenly you move from, say, 20% of the market being refinanced to 50% of the market, that is going to, that is going to shift this dynamic. But I think that we as an industry, along with our correspondents, I'm aware, are in, are in fairly solid shape for, let's say, a $2.4-$2.5 trillion market. Anything well past that, we'd need to bring on additional, additional, capacity.

Jason Weaver

analyst
#16

Got it. That's helpful to know. Thanks.

David Spector

executive
#17

Thank you, Jason.

Eric Hagen

analyst
#18

Hello there, and hello once more. I believe I've only got a single question here. To be honest, I'm not sure whether PMT has ever parted with any MSRs at any point, but might you view that as something worth doing — perhaps when a favorable chance arises, or as a way to manage risk and bring down leverage on the balance sheet?

David Spector

executive
#19

Sure, we'd take a look at it. One thing I feel genuinely good about in 2025 — and honestly this has been a running theme across the years — is how much more nimble and responsive we've become when it comes to running the portfolio. So as we've been lucky enough to bring in capital, to concentrate on being in a spot to pay down the convert and handle other items, if we reach a point where we can identify assets delivering better returns than MSRs, naturally we'd examine that possibility. The MSR transaction we completed out of PFSI shows it — this leadership group understands how to sell, close, and move servicing. So that's definitely something we'd consider.

Eric Hagen

analyst
#20

Great. That's helpful color. Thank you.

David Spector

executive
#21

Thanks, Eric.

Trevor Cranston

analyst
#22

Could you share your observations regarding how spreads have been behaving in the non-Agency market during January? Given how much tightening has occurred in the Agency space, has that carried over into any notable shift in securitization execution? Thanks.

Daniel Perotti

executive
#23

Right. On the whole, when it comes to the non-Agency side, spreads have held steady or moved tighter, tracking Agency spreads. And we keep seeing pretty strong appetite for securitizations as of January, so all told that has helped our ongoing securitization efforts. We flagged what we did on that front in January. For each collateral type we've been issuing under so far — non-owner occupied jumbo and Agency-eligible owner occupied — we finished one deal apiece. So like I said, solid demand for both, and we still view the market as supportive of what we're doing with securitizations.

Trevor Cranston

analyst
#24

Understood. All right, so moving on to the slide covering expected returns — from what I can tell, the yields on the CRT position appear quite attractive relative to the projections you folks have for the fresh subordinate retentions. So, should we anticipate additional chances to sell selectively out of the CRT book, or has that roughly arrived at a stage where it will probably sit in a steadier run-off pattern from here?

Daniel Perotti

executive
#25

What we actually sold out of the CRT book were CRTs that weren't tied specifically to PMT collateral—ones we'd picked up opportunistically back when spreads were wider. Essentially, spreads barely tightened, and the returns on those fell under our threshold, so we exited that entire third-party CRT opportunistic position. We've kept, you know, all of the credit risk transfer tied to our lender credit risk share that came straight out of our production, from PMT's production. Our expectation is that we'll keep holding that. A portion of it has sat on our books for, you know, a pretty long stretch at this point; in fact, one of our deals, you know, that carried a 10-year maturity, matured late last year. A handful of the smaller deals will mature as we go along. With the return profile and the truly high-quality nature of the underlying loans—which have really substantial home price appreciation, low mark-to-market LTVs, high FICOs, you know, low expected future credit losses—you know, we'd expect to keep that position going forward.

Trevor Cranston

analyst
#26

Got it. Okay, that makes sense. Thank you.

David Spector

executive
#27

We appreciate everyone being here. This year's changes at PMT are something we feel great about, and we're eager for what 2026 will bring. Should anything else come to mind, our Investor Relations team is available to help, and we're grateful for your time and the considerate questions.

Operator

operator
#28

The call has now ended. You may now disconnect.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete PennyMac Mortgage Investment Trust transcript — plus 131,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

For developers and AI pipelines

Programmatic access to PennyMac Mortgage Investment Trust earnings transcripts and 131,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in PennyMac Mortgage Investment Trust or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.